Viewing StudyNCT01661868



Ignite Creation Date: 2024-05-06 @ 12:48 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01661868
Status: WITHDRAWN
Last Update Posted: 2012-08-21
First Post: 2011-10-24

Brief Title: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-08
Start Date Type: None
Primary Completion Date: 2012-08
Primary Completion Date Type: ACTUAL
Completion Date: 2012-08
Completion Date Type: ACTUAL
First Submit Date: 2011-10-24
First Submit QC Date: August 7 2012
Study First Post Date: 2012-08-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-08-18
Last Update Post Date: 2012-08-21
Last Update Post Date Type: ESTIMATED